Technology to perform prostate biopsies has been relatively unchanged since the 1980′s. Traditional techniques only sample the lower portion of the prostate, yet nearly 30 percent of cancers are located outside this zone.

For men with ongoing concern for cancer—persistently elevated prostate specific antigen (PSA) (a blood marker for prostate cancer) and repeatedly negative or normal biopsies—a new technique, MR fusion guided prostate biopsy, may hold promise.

READ FULL ARTICLE Curated publisher From Forbes